Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study


Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., ...More

JOURNAL OF RHEUMATOLOGY, vol.32, no.1, pp.98-105, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 1
  • Publication Date: 2005
  • Journal Name: JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.98-105
  • Istanbul University Affiliated: Yes

Abstract

Objective. To determine the effect of the tumor necrosis factor-a blocker-etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behcet's disease (BD).